These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21486110

  • 21. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
    Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M.
    Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
    [Abstract] [Full Text] [Related]

  • 22. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity.
    Zack M, Poulos CX.
    J Psychopharmacol; 2009 Aug; 23(6):660-71. PubMed ID: 18583430
    [Abstract] [Full Text] [Related]

  • 23. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249
    [Abstract] [Full Text] [Related]

  • 24. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
    Kovanen L, Basnet S, Castrén S, Pankakoski M, Saarikoski ST, Partonen T, Alho H, Lahti T.
    Eur Addict Res; 2016 Oct 01; 22(2):70-9. PubMed ID: 26339899
    [Abstract] [Full Text] [Related]

  • 25. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
    McElroy SL, Arnold LM, Shapira NA, Keck PE, Rosenthal NR, Karim MR, Kamin M, Hudson JI.
    Am J Psychiatry; 2003 Feb 01; 160(2):255-61. PubMed ID: 12562571
    [Abstract] [Full Text] [Related]

  • 26. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun 01; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 27. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 Jun 01; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 28. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE.
    Bipolar Disord; 2007 Jun 01; 9(4):426-34. PubMed ID: 17547588
    [Abstract] [Full Text] [Related]

  • 29. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F, Hebrani P, Rezaei Ardani A, Rafee E.
    Arch Iran Med; 2011 Jul 01; 14(4):270-5. PubMed ID: 21726104
    [Abstract] [Full Text] [Related]

  • 30. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 01; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 32. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
    Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF, Topiramate Essential Tremor Study Investigators.
    Neurology; 2006 Mar 14; 66(5):672-7. PubMed ID: 16436648
    [Abstract] [Full Text] [Related]

  • 33. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 14; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 34. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
    Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA.
    Arch Intern Med; 2005 Jul 25; 165(14):1600-5. PubMed ID: 16043677
    [Abstract] [Full Text] [Related]

  • 35. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Jul 25; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 36. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR, Bruno A, Pandolfo G, Micò U, Bellinghieri PM, Scimeca G, Cacciola M, Campolo D, Settineri S, Zoccali R.
    J Psychopharmacol; 2011 May 25; 25(5):667-74. PubMed ID: 20615930
    [Abstract] [Full Text] [Related]

  • 37. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
    Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE, EPMN-106/INT-28 Investigators.
    Acta Neurol Scand; 2005 Oct 25; 112(4):214-22. PubMed ID: 16146489
    [Abstract] [Full Text] [Related]

  • 38. An open-label trial of acamprosate in the treatment of pathological gambling.
    Black DW, McNeilly DP, Burke WJ, Shaw MC, Allen J.
    Ann Clin Psychiatry; 2011 Nov 25; 23(4):250-6. PubMed ID: 22073381
    [Abstract] [Full Text] [Related]

  • 39. A single-blind study of 'as-needed' ecopipam for gambling disorder.
    Grant JE, Odlaug BL, Black DW, Fong T, Davtian M, Chipkin R, Kim SW.
    Ann Clin Psychiatry; 2014 Aug 25; 26(3):179-86. PubMed ID: 25166480
    [Abstract] [Full Text] [Related]

  • 40. Self-reported and neuropsychological measures of impulsivity in pathological gambling.
    Fuentes D, Tavares H, Artes R, Gorenstein C.
    J Int Neuropsychol Soc; 2006 Nov 25; 12(6):907-12. PubMed ID: 17064453
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.